GAMMA Investing’s iShares Biotechnology ETF IBB Stock Holding History

GAMMA Investing’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127K	Hold	667	–	–	﹤0.01%	1632
2026 Q1	$113K	Buy	667 +329	+97%	+$56.3K	0.01%	1576
2025 Q4	$57.1K	Hold	338	–	–	﹤0.01%	1984
2025 Q3	$48.8K	Sell	338 -39	-10%	-$5.32K	﹤0.01%	2009
2025 Q2	$47.7K	Hold	377	–	–	﹤0.01%	1972
2025 Q1	$48.3K	Hold	377	–	–	﹤0.01%	1815
2024 Q4	$49.9K	Hold	377	–	–	﹤0.01%	1662
2024 Q3	$54.9K	Hold	377	–	–	0.01%	1424
2024 Q2	$51.8K	Hold	377	–	–	0.01%	1172
2024 Q1	$51.8K	Hold	377	–	–	0.01%	1029
2023 Q4	$50.7K	Buy	+377	New	+$46K	0.01%	890

Other funds holding IBB

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

CMH Wealth Management Portsmouth, New Hampshire $655M AUM 25.75% 1-Year Est. Return

Chesley Taft & Associates Chicago, Illinois $2.57B AUM 22.93% 1-Year Est. Return